Literature DB >> 17493300

Linking evidence from health technology assessments to policy and decision making: the Alberta model.

Henry Z Borowski1, Jon Brehaut, David Hailey.   

Abstract

OBJECTIVES: The objective of this study was to develop and implement a decision-making process for public funding of health services that links policy areas with health technology assessment and input from interested parties.
METHODS: Health authorities, assessment organizations, and healthcare professionals were consulted as a follow-up to recommendations of an expert panel established by the Alberta government. The methods involved formulation of an eight-stage, collaborative process that incorporates identification through the health ministry of health technologies requiring review, assessment of the technologies using expert groups in Alberta, and consultation and formulation of advice within the ministry to inform ministerial funding decisions.
RESULTS: All components of the decision process have been put in place and have collaborated to provide advice to inform policy on provincial health services. Of nineteen technologies selected for review, five have been completed and decisions made: laparoscopic adjustable gastric banding, fetal fibronectin assay for premature labor, newborn screening for cystic fibrosis, newborn screening for inborn errors of metabolism, and gastric electrical stimulation. A further six reviews are in progress, and reviews of the remaining technologies are planned for 2007.
CONCLUSIONS: Bridging the evidence-to-policy gap is more likely to succeed when the policy community is actively engaged and an explicit model is used to put health technology assessment into practice.

Entities:  

Mesh:

Year:  2007        PMID: 17493300     DOI: 10.1017/S0266462307070250

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  8 in total

1.  Newborn screening for cystic fibrosis in Alberta: Two years of experience.

Authors:  Margaret Lilley; Susan Christian; Stacey Hume; Patrick Scott; Mark Montgomery; Lisa Semple; Peter Zuberbuhler; Joan Tabak; Fiona Bamforth; Martin J Somerville
Journal:  Paediatr Child Health       Date:  2010-11       Impact factor: 2.253

2.  The role of surgeons in identifying emerging technologies for health technology assessment.

Authors:  Tania Stafinski; Leigh-Ann Topfer; Ken Zakariasen; Devidas Menon
Journal:  Can J Surg       Date:  2010-04       Impact factor: 2.089

3.  Economic evidence at the local level : options for making it more useful.

Authors:  Kees van Gool; Gisselle Gallego; Marion Haas; Rosalie Viney; Jane Hall; Robyn Ward
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

Review 4.  Health technology funding decision-making processes around the world: the same, yet different.

Authors:  Tania Stafinski; Devidas Menon; Donald J Philippon; Christopher McCabe
Journal:  Pharmacoeconomics       Date:  2011-06       Impact factor: 4.981

Review 5.  Health technology assessment: the journey continues.

Authors:  Devidas Menon
Journal:  CMAJ       Date:  2014-08-11       Impact factor: 8.262

6.  Engaging the public in priority-setting for health technology assessment: findings from a citizens' jury.

Authors:  Devidas Menon; Tania Stafinski
Journal:  Health Expect       Date:  2008-09       Impact factor: 3.377

7.  Stakeholder engagement in economic evaluation: Protocol for using the nominal group technique to elicit patient, healthcare provider, and health system stakeholder input in the development of an early economic evaluation model of chimeric antigen receptor T-cell therapy.

Authors:  Kednapa Thavorn; Justin Presseau; Mackenzie Wilson; Terry Hawrysh; Ian D Graham; Harold Atkins; Natasha Kekre; Doug Coyle; Manoj M Lalu; Dean A Fergusson; Kelvin Kw Chan; Daniel A Ollendorf
Journal:  BMJ Open       Date:  2021-08-12       Impact factor: 2.692

8.  Showing Value in Newborn Screening: Challenges in Quantifying the Effectiveness and Cost-Effectiveness of Early Detection of Phenylketonuria and Cystic Fibrosis.

Authors:  Scott D Grosse
Journal:  Healthcare (Basel)       Date:  2015-11-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.